rss
BMJ Case Reports 2009; doi:10.1136/bcr.09.2008.0857
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia

  1. Brigitte Granel1,
  2. Pascal Rossi1,
  3. Fanny Bernard1,
  4. Isabelle Dettori2,
  5. Regis Costello3,
  6. Anne Laurence Demoux1,
  7. Denis Bagneres1,
  8. Pierre Lafforgue4,
  9. Yves Frances1
  1. 1
    Hopital Nord, Internal Medicine, Chemin des Bourrely, Marseille, 13915, France
  2. 2
    Etablissement Français du Sang, Boulevard Baille, Marseille, 13385, France
  3. 3
    Hopital Nord, Haematology, Chemin des Bourrely, Marseille, 13915, France
  4. 4
    Hopital Conception, Rheumatology, Boulevard Baille, Marseille, 13385, France
  1. Brigitte Granel, bgranel{at}ap-hm.fr
  • Published 6 March 2009

Summary

Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.

This Article

  1. Summary
  2. Full text

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog